BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/9/2021 10:25:22 AM | Browse: 525 | Download: 1134
 |
Received |
|
2021-01-28 16:50 |
|
Peer-Review Started |
|
2021-01-28 16:55 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-06 16:30 |
|
Revised |
|
2021-05-24 21:09 |
|
Second Decision |
|
2021-07-05 05:52 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-07-06 09:28 |
|
Articles in Press |
|
2021-07-06 09:28 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-15 08:53 |
|
Typeset the Manuscript |
|
2021-08-04 05:54 |
|
Publish the Manuscript Online |
|
2021-08-09 10:25 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Case Control Study |
| Article Title |
Clinical significance of serum miR-129-5p in patients with diabetes mellitus presenting macrovascular complications
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Xiao-Yun He and Chun-Lin Ou |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81903032 |
| China Postdoctoral Science Foundation |
2020M672520 |
| Research Program of Hunan Health Commission, China |
202103030659 |
| Youth Fund of Xiangya Hospital |
2018Q011 |
|
| Corresponding Author |
Chun-Lin Ou, PhD, Academic Research, Department of Pathology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Kaifu District, Changsha 410008, Hunan Province, China. ouchunlin@csu.edu.cn |
| Key Words |
Diabetes mellitus; Diabetic macrovascular complications; MircoRNA; Diagnosis; Therapy |
| Core Tip |
Diabetic macrovascular complications (DMCs) are the most common complications encountered during diabetes mellitus (DM) with extremely high mortality rates. Therefore, there is an urgent need to identify specific and sensitive biomarkers for the early diagnosis of DMCs. Here, we revealed that the high serum miR-129-5p expression is related to the development of DMCs and can be employed as a novel early diagnostic biomarker for DM combined with macrovascular complications. |
| Publish Date |
2021-08-09 10:25 |
| Citation |
He XY, Ou CL. Clinical significance of serum miR-129-5p in patients with diabetes mellitus presenting macrovascular complications. World J Diabetes 2021; 12(8): 1282-1291 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i8/1282.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i8.1282 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
